JNJ vs EW
By Alex · Tickerpine
Johnson & Johnson vs Edwards Lifesciences Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | EW |
|---|---|---|
| Price | $263.81 | $89.07 |
| Market cap | $635.07B | $51.34B |
| P/E ratio | 40.0 | 53.0 |
| ROE | 20.02% | 9.18% |
| Profit margin | 16.20% | 15.43% |
| Revenue growth | 5.90% | 13.60% |
| Dividend yield | 2.03% | 0.00% |
| Beta | 0.21 | 0.86 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs EW in plain English
- JNJ is the bigger company — about 12.4× the market cap of EW.
- JNJ is cheaper on earnings (P/E 40.0 vs 53.0).
- JNJ earns a higher return on equity (20% vs 9%).
- EW is growing revenue faster (14% vs 6%).
- JNJ pays a dividend (2.03%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
EW return calculator
See what $1,000 in Edwards Lifesciences Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.